214 related articles for article (PubMed ID: 17484932)
21. Chemotherapy is of limited efficacy in the control of contralateral testicular intraepithelial neoplasia in patients with testicular germ cell cancer.
Kleinschmidt K; Dieckmann KP; Georgiew A; Loy V; Weissbach L
Oncology; 2009; 77(1):33-9. PubMed ID: 19440001
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant treatment in the management of testis-confined germ cell tumours after orchidectomy.
Sava T; Consoli F; Santo A; Cetto GL
BJU Int; 2008 Jan; 101(2):155-9. PubMed ID: 17662077
[TBL] [Abstract][Full Text] [Related]
23. [Adjuvant treatment for stage I of testicular germ cell tumours].
Lakomý R; Poprach A; Nēmecek R; Vyskocil J; Ondrová B; Kocák I; Kocáková I; Rehák Z; Vyzula R
Klin Onkol; 2009; 22(1):22-6. PubMed ID: 19534436
[TBL] [Abstract][Full Text] [Related]
24. Reversibility of the effects of subchronic exposure to the cancer chemotherapeutics bleomycin, etoposide, and cisplatin on spermatogenesis, fertility, and progeny outcome in the male rat.
Marcon L; Hales BF; Robaire B
J Androl; 2008; 29(4):408-17. PubMed ID: 18296477
[TBL] [Abstract][Full Text] [Related]
25. A postulated role of testosterone for prevention of cisplatin gonadal toxicity.
Aminsharifi AR; Talaei T; Kumar V; Sabayan B; Samani S; Mohamadhoseini E
Med Hypotheses; 2007; 68(3):525-7. PubMed ID: 17045414
[TBL] [Abstract][Full Text] [Related]
26. [Testicular cancer and male fertility].
Mottet N
Prog Urol; 2000 Apr; 10(2):193-9. PubMed ID: 10857134
[TBL] [Abstract][Full Text] [Related]
27. Viable germ cell tumor at postchemotherapy retroperitoneal lymph node dissection: can we predict patients at risk of disease progression?
Spiess PE; Tannir NM; Tu SM; Brown GA; Liu P; Kamat AM; Wood CG; Evans JG; Pisters LL
Cancer; 2007 Dec; 110(12):2700-8. PubMed ID: 17948916
[TBL] [Abstract][Full Text] [Related]
28. Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.
Pectasides D; Pectasides E; Papaxoinis G; Skondra M; Gerostathou M; Karageorgopoulou S; Kamposioras C; Tountas N; Koumarianou A; Psyrri A; Macheras A; Economopoulos T
J Androl; 2009; 30(3):280-6. PubMed ID: 19136393
[TBL] [Abstract][Full Text] [Related]
29. Testicular cancer trends as 'whistle blowers' of testicular developmental problems in populations.
Skakkebaek NE; Rajpert-De Meyts E; Jørgensen N; Main KM; Leffers H; Andersson AM; Juul A; Jensen TK; Toppari J
Int J Androl; 2007 Aug; 30(4):198-204; discussion 204-5. PubMed ID: 17705804
[TBL] [Abstract][Full Text] [Related]
30. Testicular cancer patients: considerations in long-term follow-up.
Gospodarowicz M
Hematol Oncol Clin North Am; 2008 Apr; 22(2):245-55, vi. PubMed ID: 18395148
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
J Urol; 2009 Jun; 181(6):2526-32. PubMed ID: 19371895
[TBL] [Abstract][Full Text] [Related]
32. Fertility and testis cancer.
Presti JC; Herr HW; Carroll PR
Urol Clin North Am; 1993 Feb; 20(1):173-9. PubMed ID: 8434435
[TBL] [Abstract][Full Text] [Related]
33. [What's new in 2008 in the field of basic and clinical research in testicular and penile cancer?].
Phé V; Rouprêt M; Mottet N
Prog Urol; 2009 May; 19 Suppl 2():S51-5. PubMed ID: 19447329
[TBL] [Abstract][Full Text] [Related]
34. The management of stage I nonseminomatous testicular germ cell tumors.
Pectasides D; Farmakis D; Pectasides M
Oncology; 2006; 71(3-4):151-8. PubMed ID: 17646698
[TBL] [Abstract][Full Text] [Related]
35. Update on testicular germ cell tumors.
Mannuel HD; Hussain A
Curr Opin Oncol; 2009 May; 21(3):254-9. PubMed ID: 19363342
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of seminoma I stage disease].
Vyskocil J; Poprach A; Petrákova K; Lakomý R; Vyzula R; Coupek P
Klin Onkol; 2008; 21(3):86-92. PubMed ID: 19097416
[TBL] [Abstract][Full Text] [Related]
37. Is full bilateral retroperitoneal lymph node dissection always necessary for postchemotherapy residual tumor?
Beck SD; Foster RS; Bihrle R; Donohue JP; Einhorn LH
Cancer; 2007 Sep; 110(6):1235-40. PubMed ID: 17665498
[TBL] [Abstract][Full Text] [Related]
38. Laparoscopic retroperitoneal lymph node dissection combined with adjuvant chemotherapy for pathological stage II disease in nonseminomatous germ cell tumours: a 15-year experience.
Cresswell J; Scheitlin W; Gozen A; Lenz E; Teber D; Rassweiler J
BJU Int; 2008 Sep; 102(7):844-8. PubMed ID: 18537954
[TBL] [Abstract][Full Text] [Related]
39. Isolated polyarteritis nodosa of the male reproductive system associated with a germ cell tumor of the testis: a case report.
Fleischmann A; Studer UE
Cardiovasc Pathol; 2007; 16(6):354-6. PubMed ID: 18005875
[TBL] [Abstract][Full Text] [Related]
40. Surveillance in stage I nonseminomatous germ cell tumours of the testis.
Zuniga A; Kakiashvili D; Jewett MA
BJU Int; 2009 Nov; 104(9 Pt B):1351-6. PubMed ID: 19840012
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
